Staphylococcus aureus CIP 106415 is an aerobe, Gram-positive, coccus-shaped bacterium of the family Staphylococcaceae.
Gram-positive coccus-shaped aerobe genome sequence Bacteria| @ref 20215 |
|
Last LPSN update
2026-02-09 11:33:06 |
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Caryophanales |
| Family Staphylococcaceae |
| Genus Staphylococcus |
| Species Staphylococcus aureus |
| Full scientific name Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68375 | 22599 ChEBI | arabinose | - | fermentation | from API ID32STA |
| 68375 | 29016 ChEBI | arginine | + | hydrolysis | from API ID32STA |
| 68375 | 17057 ChEBI | cellobiose | - | fermentation | from API ID32STA |
| 68375 | 15824 ChEBI | D-fructose | + | fermentation | from API ID32STA |
| 68375 | 17634 ChEBI | D-glucose | + | fermentation | from API ID32STA |
| 68375 | 16899 ChEBI | D-mannitol | + | fermentation | from API ID32STA |
| 68375 | 16024 ChEBI | D-mannose | + | fermentation | from API ID32STA |
| 68375 | 16988 ChEBI | D-ribose | - | fermentation | from API ID32STA |
| 68375 | 4853 ChEBI | esculin | - | hydrolysis | from API ID32STA |
| 39515 | 606565 ChEBI | hippurate | + | hydrolysis | |
| 68375 | 17716 ChEBI | lactose | + | fermentation | from API ID32STA |
| 68375 | 17306 ChEBI | maltose | + | fermentation | from API ID32STA |
| 68375 | 59640 ChEBI | N-acetylglucosamine | + | fermentation | from API ID32STA |
| 68375 | 17632 ChEBI | nitrate | + | reduction | from API ID32STA |
| 39515 | 17632 ChEBI | nitrate | + | reduction | |
| 39515 | 16301 ChEBI | nitrite | - | reduction | |
| 68375 | 18257 ChEBI | ornithine | - | degradation | from API ID32STA |
| 68375 | 16634 ChEBI | raffinose | - | fermentation | from API ID32STA |
| 68375 | 17992 ChEBI | sucrose | + | fermentation | from API ID32STA |
| 68375 | 27082 ChEBI | trehalose | + | fermentation | from API ID32STA |
| 68375 | 32528 ChEBI | turanose | + | fermentation | from API ID32STA |
| 68375 | 16199 ChEBI | urea | - | hydrolysis | from API ID32STA |
| @ref | ChEBI | Metabolite | Is sensitive | Sensitivity conc. | |
|---|---|---|---|---|---|
| 68375 | 28368 | novobiocin | 1.8 µg | from API ID32STA |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 39515 | alcohol dehydrogenase | - | 1.1.1.1 | |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68375 | alkaline phosphatase | + | 3.1.3.1 | from API ID32STA |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | + | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 39515 | amylase | - | ||
| 68375 | arginine dihydrolase | + | 3.5.3.6 | from API ID32STA |
| 39515 | beta-galactosidase | + | 3.2.1.23 | |
| 68375 | beta-galactosidase | - | 3.2.1.23 | from API ID32STA |
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68375 | beta-glucosidase | - | 3.2.1.21 | from API ID32STA |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 68375 | beta-glucuronidase | - | 3.2.1.31 | from API ID32STA |
| 39515 | caseinase | + | 3.4.21.50 | |
| 39515 | catalase | + | 1.11.1.6 | |
| 39515 | coagulase | + | ||
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 39515 | DNase | + | ||
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 39515 | gamma-glutamyltransferase | - | 2.3.2.2 | |
| 39515 | gelatinase | - | ||
| 68375 | L-arginine arylamidase | - | from API ID32STA | |
| 39515 | lecithinase | - | ||
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 39515 | lipase | + | ||
| 68382 | lipase (C 14) | - | from API zym | |
| 39515 | lysine decarboxylase | - | 4.1.1.18 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 39515 | ornithine decarboxylase | - | 4.1.1.17 | |
| 68375 | ornithine decarboxylase | - | 4.1.1.17 | from API ID32STA |
| 39515 | oxidase | - | ||
| 39515 | phenylalanine ammonia-lyase | - | 4.3.1.24 | |
| 39515 | protease | + | ||
| 68375 | pyrrolidonyl arylamidase | + | 3.4.19.3 | from API ID32STA |
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 39515 | tween esterase | + | ||
| 39515 | urease | - | 3.5.1.5 | |
| 68375 | urease | - | 3.5.1.5 | from API ID32STA |
| 68382 | valine arylamidase | - | from API zym |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM101906v2 assembly for Staphylococcus aureus FDAARGOS_37 | contig | GCA_001019065   | 1280.4823  | 2690315744  | 1280 | 76.93 | |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Inhibitory potential of pentagalloyl glucose against efflux pumps in Staphylococcus aureus. | Harikumar K, Singh U, Ramaraj SK, Rekha LA, Nayak A, Ghosh P, Prasad R, Philip A, Sahu S, Nelson-Sathi S. | RSC Adv | 10.1039/d5ra03958d | 2025 | | |
| In Vitro Venous Catheter Material Comparison: Microbial Adhesion in a Thrombotic Blood Flow Model. | LeRoy K, Donahue D. | J Infus Nurs | 10.1097/nan.0000000000000615 | 2025 | | |
| Antibacterial and Antibiofilm Activities of Hydralazine, an Antihypertensive Drug: In Vitro and In Silico Approaches. | Pereira AMG, da Silva BF, Araujo IMF, Aguiar FKC, Coelho PAT, Costa RA, Marinho MM, Marinho ES, Nunes JVS, Carneiro VA, Santos HSD. | Antibiotics (Basel) | 10.3390/antibiotics14030286 | 2025 | | |
| Afil, a Lectin from Aplysina fistularis, Exhibits Antibiofilm and Synergistic Antibacterial Activity Against Resistant Bacteria. | Andrade FRN, Silva JMS, Duarte JA, Duarte PL, Tabosa PAS, da Costa Filho MF, Marques JSN, Andrade AL, Chaves RP, de Vasconcelos MA, Nascimento E, Pinheiro U, Teixeira EH, Nagano CS, Sampaio AH, Carneiro RF. | Microorganisms | 10.3390/microorganisms13061349 | 2025 | | |
| Antibacterial and Antibiofilm Activity of Croton urticifolius Lam. Essential Oil Via Membrane Disruption. | Malveira EA, Nunes AKA, Andrade AL, Melo GLC, da Silva WMB, de Morais SM, Dos Santos HS, de Lima LB, de Albuquerque CC, do Nascimento Souza DN, Teixeira EH, de Vasconcelos MA. | Curr Microbiol | 10.1007/s00284-024-03779-6 | 2024 | | |
| Lippia grata Essential Oil Acts Synergistically with Ampicillin Against Staphylococcus aureus and its Biofilm. | Lopes APR, Andrade AL, Pinheiro AA, de Sousa LS, Malveira EA, Oliveira FFM, de Albuquerque CC, Teixeira EH, de Vasconcelos MA. | Curr Microbiol | 10.1007/s00284-024-03690-0 | 2024 | | |
| Anti-Staphylococcus aureus Activity of Volatile Phytochemicals and Their Combinations with Conventional Antibiotics Against Methicillin-Susceptible S. aureus (MSSA) and Methicillin-Resistant S. aureus (MRSA) Strains. | Nikolic I, Aleksic Sabo V, Gavric D, Knezevic P. | Antibiotics (Basel) | 10.3390/antibiotics13111030 | 2024 | | |
| Toward Enhanced Antibiotic Efficacy: Exploring the Synergistic Potential of Marine-Derived Lectins Against Human Pathogenic Bacteria. | Carneiro RF, Tabosa PAS, Candido JGS, Menezes VPP, Rocha Junior PAV, Andrade AL, Vasconcelos MA, Teixeira EH, Nagano CS, Sampaio AH. | An Acad Bras Cienc | 10.1590/0001-3765202420240072 | 2024 | | |
| Molecular Differentiation and Detection of AMR Genes from Nosocomial Staphylococcus spp. | Carneiro I, da Silva WLP, de Souza Santos DR, de Filippis I. | Pathogens | 10.3390/pathogens14050403 | 2025 | | |
| Terpyridine-based ruthenium complexes containing a 4,5-diazafluoren-9-one ligand with light-driven enhancement of biological activity. | de Alencar FMS, Gouveia FS, Oliveira GFS, Andrade AL, Vasconcelos MA, Ayala AP, Gondim ACS, Carvalho IMM, Moraes CAF, Palmeira-Mello MV, Batista AA, Lopes LGF, Sousa EHS. | Dalton Trans | 10.1039/d4dt02562h | 2025 | | |
| Vancomycin-Teixobactin Conjugates. | Padilla MSTL, Nowick JS. | J Am Chem Soc | 10.1021/jacs.4c17175 | 2025 | | |
| Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms. | Padalino G, Duggan K, Mur LAJ, Maillard JY, Brancale A, Hoffmann KF. | Microbiologyopen | 10.1002/mbo3.70011 | 2024 | | |
| Mitochondria-Targeted Curcumin: A Potent Antibacterial Agent against Methicillin-Resistant Staphylococcus aureus with a Possible Intracellular ROS Accumulation as the Mechanism of Action. | Leferman CE, Stoica L, Stoica BA, Ciubotaru AD, Badescu AC, Bogdanici CM, Neagu TP, Ghiciuc CM. | Antibiotics (Basel) | 10.3390/antibiotics12020401 | 2023 | | |
| Subplenones A-J: Dimeric Xanthones with Antibacterial Activity from the Endophytic Fungus Subplenodomus sp. CPCC 401465. | Cai G, Hu X, Zhang R, Wang J, Fang X, Pang X, Bai J, Zhang T, Zhang T, Lv H, You X, He W, Yu L. | J Nat Prod | 10.1021/acs.jnatprod.3c00628 | 2023 | | |
| Antibacterial Compounds Isolated from Endophytic Fungi Reported from 2021 to 2024. | Ortega HE, Torres-Mendoza D, Cubilla-Rios L. | Antibiotics (Basel) | 10.3390/antibiotics14070644 | 2025 | | |
| Flying under the radar: vancomycin heteroresistance in Staphylococcus epidermidis peritonitis is associated with treatment failure. | Kopczyk MK, Ramsay JP, Mulroney KT, Salisbury E, Ho WS, Carson CF, Colombi E, Paton T, Chakera A. | ASM Case Rep | 10.1128/asmcr.00007-25 | 2025 | | |
| Potent Analogues of Clovibactin from Commercially Available Amino Acid Building Blocks. | Brunicardi JEH, Small JJ, Padilla MSTL, Carrera Plancarte JI, Nowick JS. | J Org Chem | 10.1021/acs.joc.4c02828 | 2025 | | |
| Teixobactin "Swapmers" with l Tail Stereochemistry Retain Antibiotic Activity. | Griffin JH, Mendoza AT, Nowick JS. | J Org Chem | 10.1021/acs.joc.4c01674 | 2024 | | |
| Molecular and Clinical Features of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in Tertiary Care Hospitals in South India. | Sreejisha M, Shenoy MS, Shenoy MS, Dhanashree B, Chakrapani M, Bhat KG. | Sultan Qaboos Univ Med J | 10.18295/squmj.3.2023.018 | 2023 | | |
| Antibacterial and antifungal action of CTAB-containing silica nanoparticles against human pathogens. | Martins da Silva Filho P, Higor Rocha Mariano P, Lopes Andrade A, Barros Arrais Cruz Lopes J, de Azevedo Pinheiro A, Itala Geronimo de Azevedo M, Carneiro de Medeiros S, Alves de Vasconcelos M, Goncalvez da Cruz Fonseca S, Barbosa Grangeiro T, Gonzaga de Franca Lopes L, Henrique Silva Sousa E, Holanda Teixeira E, Longhinotti E. | Int J Pharm | 10.1016/j.ijpharm.2023.123074 | 2023 | | |
| Antimicrobial, Antibiofilm Activities and Synergic Effect of Triterpene 3beta,6beta,16beta-trihydroxyilup-20(29)-ene Isolated from Combretum leprosum Leaves Against Staphylococcus Strains. | Teixeira EH, Andrade AL, Pereira R, Farias LP, Monteiro GS, Marinho MM, Marinho ES, Santos HS, de Vasconcelos MA. | Curr Microbiol | 10.1007/s00284-023-03284-2 | 2023 | | |
| Fast Release of Carboxylic Acid inside Cells. | Moser P, Zelli R, Dos Santos LJ, Henry M, Sanchez-Garcia K, Caspar Y, Marro FC, Chovelon B, Saez Cabodevilla J, de Choudens SO, Faudry E, Wong YS. | ChemMedChem | 10.1002/cmdc.202500056 | 2025 | | |
| Synthesis and antibacterial activity of 2-benzylidene-3-oxobutanamide derivatives against resistant pathogens. | Sood A, Kesavan V. | RSC Med Chem | 10.1039/d3md00051f | 2023 | | |
| Enzymology | Assessing Boron-Pleuromutilin AN11251 for the Development of Antibacterial Agents. | Han MJ, Pan M, Xiao G, Yuan Y, Chen S, Zou Z. | Molecules | 10.3390/molecules28124628 | 2023 | |
| Structure-Activity Relationship Studies of the Peptide Antibiotic Clovibactin. | Brunicardi JEH, Griffin JH, Ferracane MJ, Kreutzer AG, Small J, Mendoza AT, Ziller JW, Nowick JS. | J Org Chem | 10.1021/acs.joc.4c01414 | 2024 | | |
| Investigation of Isobactin Analogues of Teixobactin. | Jones CR, Lai GH, Padilla MSTL, Nowick JS. | ACS Med Chem Lett | 10.1021/acsmedchemlett.4c00215 | 2024 | | |
| Cannabinoids as Antibacterial Agents: A Systematic and Critical Review of In Vitro Efficacy Against Streptococcus and Staphylococcus. | Niyangoda D, Aung ML, Qader M, Tesfaye W, Bushell M, Chiong F, Tsai D, Ahmad D, Samarawickrema I, Sinnollareddy M, Thomas J. | Antibiotics (Basel) | 10.3390/antibiotics13111023 | 2024 | | |
| The Influence of Chestnut Extract and Its Components on Antibacterial Activity against Staphylococcus aureus. | Stumpf S, Hostnik G, Langerholc T, Pintaric M, Kolenc Z, Bren U. | Plants (Basel) | 10.3390/plants12102043 | 2023 | | |
| Biofilm Inhibition Activity of Fennel Honey, Fennel Essential Oil and Their Combination. | Nagy-Radvanyi L, Ormai E, Koloh R, Angyan VD, Kocsis B, Bencsik-Kerekes E, Szabo P, Csikos E, Farkas A, Horvath G, Kocsis M, Balazs VL. | Microorganisms | 10.3390/microorganisms12112309 | 2024 | | |
| Heterogeneous Vancomycin Intermediate Staphylococcus aureus Infections in Diabetic and Non-Diabetic Patients - A Hospital-Based Comparative Study. | M S, Mulki SS, Shenoy S, Shenoy S, Dhanashree B, M C, Bhat G. | Infect Drug Resist | 10.2147/idr.s393415 | 2023 | | |
| Antibacterial and Anti-Quorum Sensing Properties of Silver Nanoparticles Phytosynthesized Using Embelia ruminata. | Rambaran N, Naidoo Y, Mohamed F, Chenia HY, Baijnath H. | Plants (Basel) | 10.3390/plants13020168 | 2024 | | |
| Comparing the Synergistic and Antagonistic Interactions of Ciprofloxacin and Levofloxacin Combined with Rifampin against Drug-Resistant Staphylococcus aureus: A Time-Kill Assay. | Kang YR, Chung DR, Ko JH, Huh K, Cho SY, Kang CI, Peck KR. | Antibiotics (Basel) | 10.3390/antibiotics12040711 | 2023 | | |
| Detection of Vancomycin Resistance among Methicillin-Resistant Staphylococcus aureus Strains Recovered from Children with Invasive Diseases in a Reference Pediatric Hospital. | Pardo L, Mota MI, Parnizari A, Varela A, Algorta G, Varela G. | Antibiotics (Basel) | 10.3390/antibiotics13040298 | 2024 | | |
| In silico design and mechanistic study of niosome-encapsulated curcumin against multidrug-resistant Staphylococcus aureus biofilms. | Khaleghian M, Sahrayi H, Hafezi Y, Mirshafeeyan M, Moghaddam ZS, Farasati Far B, Noorbazargan H, Mirzaie A, Ren Q. | Front Microbiol | 10.3389/fmicb.2023.1277533 | 2023 | | |
| Minimal Functionalization of Ruthenium Compounds with Enhanced Photoreactivity against Hard-to-Treat Cancer Cells and Resistant Bacteria. | Oliveira GFS, Gouveia FS, Andrade AL, de Vasconcelos MA, Teixeira EH, Palmeira-Mello MV, Batista AA, Lopes LGF, de Carvalho IMM, Sousa EHS. | Inorg Chem | 10.1021/acs.inorgchem.4c02235 | 2024 | | |
| Green Synthesis of Silver Nanoparticles from Diospyros villosa Extracts and Evaluation of Antioxidant, Antimicrobial and Anti-Quorum Sensing Potential. | Adu OT, Mohamed F, Naidoo Y, Adu TS, Chenia H, Dewir YH, Rihan H. | Plants (Basel) | 10.3390/plants11192514 | 2022 | | |
| Dual-responsive copper complex delivered by dissolvable microneedle promotes polymicrobial infection eradication and cutaneous wound healing. | Ghosh S, Ghosh S, Yeung KWK, Xu C, Wu J, Mao C, Ling Z, Okuro K, Qiao W. | Mater Today Bio | 10.1016/j.mtbio.2025.102219 | 2025 | | |
| Chestnut Honey Is Effective against Mixed Biofilms at Different Stages of Maturity. | Koloh R, Balazs VL, Nagy-Radvanyi L, Kocsis B, Kerekes EB, Kocsis M, Farkas A. | Antibiotics (Basel) | 10.3390/antibiotics13030255 | 2024 | | |
| Decrease in vancomycin MICs and prevalence of hGISA in MRSA and MSSA isolates from a German pediatric tertiary care center. | Haas K, Meyer-Buehn M, von Both U, Hubner J, Schober T. | Infection | 10.1007/s15010-023-02036-5 | 2023 | | |
| Bactericidal Activity of Superabsorbent Polymer Granules for Their Applications in Respiratory Fluid Solidification Systems. | Saraswathy M, Komath M, Ragini DD, SomanPillai SarojiniAmma P, Lathikumari SS, Akhandanandan MN. | ACS Omega | 10.1021/acsomega.3c01994 | 2023 | | |
| Antibacterial and antifungal activities of natural deep eutectic solvents. | Bedair HM, Samir TM, Mansour FR. | Appl Microbiol Biotechnol | 10.1007/s00253-024-13044-2 | 2024 | | |
| Applications of Lab on a Chip in Antimicrobial Susceptibility of Staphylococcus aureus: A Systematic Review. | Ardila CM, Zuluaga-Gomez M, Vivares-Builes AM. | Medicina (Kaunas) | 10.3390/medicina59101719 | 2023 | | |
| Decreased susceptibility to vancomycin and other mechanisms of resistance to antibiotics in Staphylococcus epidermidis as a therapeutic problem in hospital treatment. | Szemraj M, Glajzner P, Sienkiewicz M. | Sci Rep | 10.1038/s41598-023-40866-3 | 2023 | | |
| Evaluation of Antimicrobial and Antioxidant Potential of Essential Oil from Croton piauhiensis Müll. Arg. | do Vale JPC, Vasconcelos MA, Arruda FVS, Firmino NCS, Pereira AL, Andrade AL, Saker-Sampaio S, Sampaio AH, Marinho ES, Teixeira AMR, Marinho MM, Rodrigues THS, Teixeira EH, Dos Santos HS. | Curr Microbiol | 10.1007/s00284-021-02449-1 | 2021 | | |
| Microarray Analysis of the Genomic Effect of Eugenol on Methicillin-Resistant Staphylococcus aureus. | Buru AS, Neela VK, Mohandas K, Pichika MR. | Molecules | 10.3390/molecules27103249 | 2022 | | |
| Antimicrobial, Cytotoxic, and Anti-Inflammatory Activities of Tigridia vanhouttei Extracts. | Mejia-Mendez JL, Lorenzo-Leal AC, Bach H, Lopez-Mena ER, Navarro-Lopez DE, Hernandez LR, Juarez ZN, Sanchez-Arreola E. | Plants (Basel) | 10.3390/plants12173136 | 2023 | | |
| Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India. | Bakthavatchalam YD, Babu P, Munusamy E, Dwarakanathan HT, Rupali P, Zervos M, John Victor P, Veeraraghavan B. | PLoS One | 10.1371/journal.pone.0227009 | 2019 | | |
| Metabolism | Antimicrobial activity of protein-containing fractions isolated from Lactobacillus plantarum NRRL B-4496 culture. | Arrioja-Breton D, Mani-Lopez E, Bach H, Lopez-Malo A. | Braz J Microbiol | 10.1007/s42770-020-00266-5 | 2020 | |
| Biological Activities and Chemical Profiles of Kalanchoe fedtschenkoi Extracts. | Mejia-Mendez JL, Bach H, Lorenzo-Leal AC, Navarro-Lopez DE, Lopez-Mena ER, Hernandez LR, Sanchez-Arreola E. | Plants (Basel) | 10.3390/plants12101943 | 2023 | | |
| Microbiological Studies on the Influence of Essential Oils from Several Origanum Species on Respiratory Pathogens. | Piasecki B, Balazs VL, Kieltyka-Dadasiewicz A, Szabo P, Kocsis B, Horvath G, Ludwiczuk A. | Molecules | 10.3390/molecules28073044 | 2023 | | |
| Vancomycin heteroresistance among methicillin-resistant clinical isolates S. haemolyticus, S. hominis, S. simulans, and S. warneri. | Szemraj M, Lisiecki P, Glajzner P, Szewczyk EM. | Braz J Microbiol | 10.1007/s42770-022-00870-7 | 2023 | | |
| Phenotype | Phenotypic and Molecular Characterisation of Staphylococcus Aureus with Reduced Vancomycin Susceptibility Derivated in Vitro. | Xu J, Pang L, Ma XX, Hu J, Tian Y, Yang YL, Sun DD. | Open Med (Wars) | 10.1515/med-2018-0071 | 2018 | |
| Sequence Type 5 (ST5) as a Possible Predictor of Bacterial Persistence in Adult Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia Treated with Vancomycin. | Fan YX, Chen MT, Li NY, Liu XF, Yang MJ, Chen YC, Liang XY, Wu JF, Guo BN, Song SC, Zhu YQ, Zhang FY, Hang JQ, Wu SB, Shen B, Li HY, Wang Q, Luo XM, Chen QG, Zhang HF, Wang RL, Shen LH, Fu FM, Song XL, Zhang J. | Microbiol Spectr | 10.1128/spectrum.01348-22 | 2022 | | |
| Pathogenicity | Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus: A preliminary report from south India. | Amberpet R, Sistla S, Sugumar M, Nagasundaram N, Manoharan M, Parija SC. | Indian J Med Res | 10.4103/ijmr.ijmr_1976_17 | 2019 | |
| Detection of heterogeneous vancomycin intermediate resistance in MRSA isolates from Latin America. | Castro BE, Berrio M, Vargas ML, Carvajal LP, Millan LV, Rios R, Hernandez AK, Rincon S, Cubides P, Forero E, Dinh A, Seas C, Munita JM, Arias CA, Reyes J, Diaz L. | J Antimicrob Chemother | 10.1093/jac/dkaa221 | 2020 | | |
| Pathogenicity | Comparative In Vitro Activities of Oritavancin, Dalbavancin, and Vancomycin against Methicillin-Resistant Staphylococcus aureus Isolates in a Nondividing State. | Belley A, Lalonde Seguin D, Arhin F, Moeck G. | Antimicrob Agents Chemother | 10.1128/aac.00169-16 | 2016 | |
| Xanthone Dimers in Angiosperms, Fungi, Lichens: Comprehensive Review of Their Sources, Structures, and Pharmacological Properties. | Shi F, Fan M, Li H, Li S, Wang S. | Molecules | 10.3390/molecules30040967 | 2025 | | |
| Antibacterial and Antibiofilm Effect of Unifloral Honeys against Bacteria Isolated from Chronic Wound Infections. | Balazs VL, Nagy-Radvanyi L, Bencsik-Kerekes E, Koloh R, Szabo D, Kocsis B, Kocsis M, Farkas A. | Microorganisms | 10.3390/microorganisms11020509 | 2023 | | |
| Antibacterial Activities of Homemade Matrices Miming Essential Oils Compared to Commercial Ones. | Oliveira Ribeiro S, Fontaine V, Mathieu V, Abdesselam Z, Dominique B, Caroline S, Florence S. | Antibiotics (Basel) | 10.3390/antibiotics10050584 | 2021 | | |
| Antimicrobial and anti-inflammatory activities of commercial aromatizing fragrances. | Bach H, Bach H. | Future Sci OA | 10.2144/fsoa-2020-0194 | 2021 | | |
| Photo-Cross-Linked Probe-Modified Magnetic Particles for the Selective and Reliable Recovery of Nucleic Acids. | Yajima S, Koto A, Koda M, Sakamoto H, Takamura E, Suye SI. | ACS Omega | 10.1021/acsomega.1c07012 | 2022 | | |
| Nasal Carriage by Staphylococcus aureus among Healthcare Workers and Students Attending a University Hospital in Southern Brazil: Prevalence, Phenotypic, and Molecular Characteristics. | Danelli T, Duarte FC, de Oliveira TA, da Silva RS, Frizon Alfieri D, Goncalves GB, de Oliveira CF, Tavares ER, Yamauchi LM, Perugini MRE, Yamada-Ogatta SF. | Interdiscip Perspect Infect Dis | 10.1155/2020/3808036 | 2020 | | |
| Isobactins: O-acyl isopeptide prodrugs of teixobactin and teixobactin derivatives. | Jones CR, Guaglianone G, Lai GH, Nowick JS. | Chem Sci | 10.1039/d2sc02670h | 2022 | | |
| Pathogenicity | Strain-specific anti-biofilm and antibiotic-potentiating activity of 3',4'-difluoroquercetin. | Kho W, Kim MK, Jung M, Chong YP, Kim YS, Park KH, Chong Y. | Sci Rep | 10.1038/s41598-020-71025-7 | 2020 | |
| Pathogenicity | Potency and penetration of telavancin in staphylococcal biofilms. | Kirker KR, Fisher ST, James GA. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2015.05.022 | 2015 | |
| Optimal Design of THEDES Based on Perillyl Alcohol and Ibuprofen. | Silva E, Oliveira F, Silva JM, Matias A, Reis RL, Duarte ARC. | Pharmaceutics | 10.3390/pharmaceutics12111121 | 2020 | | |
| The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study. | Hussein M, Karas JA, Schneider-Futschik EK, Chen F, Swarbrick J, Paulin OKA, Hoyer D, Baker M, Zhu Y, Li J, Velkov T. | mSystems | 10.1128/msystems.00077-20 | 2020 | | |
| Transcriptomic Analysis of the Activity of a Novel Polymyxin against Staphylococcus aureus. | Zhao J, Cheah SE, Roberts KD, Nation RL, Thompson PE, Velkov T, Du Z, Johnson MD, Li J. | mSphere | 10.1128/msphere.00119-16 | 2016 | | |
| Phytochemical Screening and Bioactivities of Cactaceae Family Members Endemic to Mexico. | Rodriguez-Mendoza CA, Gonzalez Campos RE, Lorenzo-Leal AC, Bautista Rodriguez E, Paredes Juarez GA, El Kassis EG, Hernandez LR, Juarez ZN, Bach H. | Plants (Basel) | 10.3390/plants11212856 | 2022 | | |
| New bioactive secondary metabolites from fungi: 2023. | Shi Y, Ji M, Dong J, Shi D, Wang Y, Liu L, Feng S, Liu L. | Mycology | 10.1080/21501203.2024.2354302 | 2024 | | |
| Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus? | Bakthavatchalam YD, Ralph R, Veeraraghavan B, Babu P, Munusamy E. | Infect Dis Ther | 10.1007/s40121-018-0224-z | 2019 | | |
| Using prodigiosin against some gram-positive and gram-negative bacteria and Trypanosoma cruzi. | Herraez R, Mur A, Merlos A, Vinas M, Vinuesa T. | J Venom Anim Toxins Incl Trop Dis | 10.1590/1678-9199-jvatitd-2019-0001 | 2019 | | |
| Bioactivities of Flavonoids from Lopezia racemosa. | Vergara Barragan E, Bach H, Meza-Reyes S, Montiel-Smith S, Sanchez-Arreola E, Hernandez LR. | Biomed Res Int | 10.1155/2019/3286489 | 2019 | | |
| Formulation, preparation of niosome loaded zinc oxide nanoparticles and biological activities. | Rezaei H, Iranbakhsh A, Sepahi AA, Mirzaie A, Larijani K. | Sci Rep | 10.1038/s41598-024-67509-5 | 2024 | | |
| Nanotechnology in combating biofilm: A smart and promising therapeutic strategy. | Mohanta YK, Chakrabartty I, Mishra AK, Chopra H, Mahanta S, Avula SK, Patowary K, Ahmed R, Mishra B, Mohanta TK, Saravanan M, Sharma N. | Front Microbiol | 10.3389/fmicb.2022.1028086 | 2022 | | |
| Surface Functionalization of Ureteral Stents-Based Polyurethane: Engineering Antibacterial Coatings. | Ecevit K, Silva E, Rodrigues LC, Aroso I, Barros AA, Silva JM, Reis RL. | Materials (Basel) | 10.3390/ma15051676 | 2022 | | |
| Antimicrobial, Cytotoxic, and Anti-Inflammatory Activities of Pimenta dioica and Rosmarinus officinalis Essential Oils. | Lorenzo-Leal AC, Palou E, Lopez-Malo A, Bach H. | Biomed Res Int | 10.1155/2019/1639726 | 2019 | | |
| Composition, Cytotoxic and Antimicrobial Activities of Satureja intermedia C.A.Mey Essential Oil. | Sharifi-Rad J, Sharifi-Rad M, Hoseini-Alfatemi SM, Iriti M, Sharifi-Rad M, Sharifi-Rad M. | Int J Mol Sci | 10.3390/ijms160817812 | 2015 | | |
| Enzymology | Characteristics of glycopeptide-resistant Staphylococcus aureus strains isolated from inpatients of three teaching hospitals in Warsaw, Poland. | Szymanek-Majchrzak K, Mlynarczyk A, Mlynarczyk G. | Antimicrob Resist Infect Control | 10.1186/s13756-018-0397-y | 2018 | |
| Proteome | Tolypocladamide H and the Proposed Tolypocladamide NRPS in Tolypocladium Species. | Tehan RM, Blount RR, Goold RL, Mattos DR, Spatafora NR, Tabima JF, Gazis R, Wang C, Ishmael JE, Spatafora JW, McPhail KL. | J Nat Prod | 10.1021/acs.jnatprod.2c00153 | 2022 | |
| Pathogenicity | Repurposing Thiram and Disulfiram as Antibacterial Agents for Multidrug-Resistant Staphylococcus aureus Infections. | Long TE. | Antimicrob Agents Chemother | 10.1128/aac.00898-17 | 2017 | |
| The role of the msaABCR operon in implant-associated chronic osteomyelitis in Staphylococcus aureus USA300 LAC. | Sahukhal GS, Tucci M, Benghuzzi H, Wilson G, Elasri MO. | BMC Microbiol | 10.1186/s12866-020-01964-8 | 2020 | | |
| The Potential Role of Sulbactam and Cephalosporins Plus Daptomycin Against Daptomycin-Nonsusceptible VISA and H-VISA Isolates: An in Vitro Study. | Lai CC, Chen CC, Lu YC, Lin TP, Chen HJ, Su BA, Chao CM, Chuang YC, Tang HJ. | Antibiotics (Basel) | 10.3390/antibiotics8040184 | 2019 | | |
| Pathogenicity | Evolution and Antibacterial Evaluation of 8-Hydroxy-cycloberberine Derivatives as a Novel Family of Antibacterial Agents Against MRSA. | Yang YS, Wei W, Hu XX, Tang S, Pang J, You XF, Fan TY, Wang YX, Song DQ. | Molecules | 10.3390/molecules24050984 | 2019 | |
| Antioxidant and antibacterial activity of Trametes polyzona (Pers.) Justo. | Adongbede EM, Jaiswal YS, Davis SS, Randolph PD, Huo LN, Williams LL. | Food Sci Biotechnol | 10.1007/s10068-019-00642-4 | 2020 | | |
| Photothermal/Photoacoustic Therapy Combined with Metal-Based Nanomaterials for the Treatment of Microbial Infections. | Mammari N, Duval RE. | Microorganisms | 10.3390/microorganisms11082084 | 2023 | | |
| Chemical composition and antibacterial and cytotoxic activities of Allium hirtifolium Boiss. | Ismail S, Jalilian FA, Talebpour AH, Zargar M, Shameli K, Sekawi Z, Jahanshiri F. | Biomed Res Int | 10.1155/2013/696835 | 2013 | | |
| Phytochemical and biological activities of some Iranian medicinal plants. | Dini S, Chen Q, Fatemi F, Asri Y. | Pharm Biol | 10.1080/13880209.2022.2046112 | 2022 | | |
| Pathogenicity | Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing. | Belley A, McKay GA, Arhin FF, Sarmiento I, Beaulieu S, Fadhil I, Parr TR, Moeck G. | Antimicrob Agents Chemother | 10.1128/aac.00760-10 | 2010 | |
| Therapeutic Role of Deep Eutectic Solvents Based on Menthol and Saturated Fatty Acids on Wound Healing. | Silva JM, Pereira CV, Mano F, Silva E, Castro VIB, Sa-Nogueira I, Reis RL, Paiva A, Matias AA, Duarte ARC. | ACS Appl Bio Mater | 10.1021/acsabm.9b00598 | 2019 | | |
| Pathogenicity | Clinical and Genetic Risk Factors for Biofilm-Forming Staphylococcus aureus. | Luther MK, Parente DM, Caffrey AR, Daffinee KE, Lopes VV, Martin ET, LaPlante KL. | Antimicrob Agents Chemother | 10.1128/aac.02252-17 | 2018 | |
| Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain. | Chen FJ, Lauderdale TL, Lee CH, Hsu YC, Huang IW, Hsu PC, Yang CS. | Front Microbiol | 10.3389/fmicb.2018.01086 | 2018 | | |
| Methicillin-Resistant Staphylococcus aureus Sequence Type (ST) 5 Isolates from Health Care and Agricultural Sources Adhere Equivalently to Human Keratinocytes. | Hau SJ, Kellner S, Eberle KC, Waack U, Brockmeier SL, Haan JS, Davies PR, Frana T, Nicholson TL. | Appl Environ Microbiol | 10.1128/aem.02073-17 | 2018 | | |
| Low prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates among Connecticut veterans. | Fink SL, Martinello RA, Campbell SM, Murray TS. | Antimicrob Agents Chemother | 10.1128/aac.05024-11 | 2012 | | |
| The Genus Diospyros: A Review of Novel Insights into the Biological Activity and Species of Mozambican Flora. | Ribeiro A, Serrano R, da Silva IBM, Gomes ET, Pinto JF, Silva O. | Plants (Basel) | 10.3390/plants12152833 | 2023 | | |
| Isolation, Structure Elucidation, and First Total Synthesis of Quinomycins K and L, Two New Octadepsipeptides from the Maowei Sea Mangrove-Derived Streptomyces sp. B475. | Lu Q, Wu G, Hao X, Hu X, Cai H, Liu X, You X, Guo H, Sun C. | Mar Drugs | 10.3390/md21030143 | 2023 | | |
| The Antimicrobial Properties of Cannabis and Cannabis-Derived Compounds and Relevance to CB2-Targeted Neurodegenerative Therapeutics. | Hong H, Sloan L, Saxena D, Scott DA. | Biomedicines | 10.3390/biomedicines10081959 | 2022 | | |
| Genetics | Convergent Evolution Driven by Rifampin Exacerbates the Global Burden of Drug-Resistant Staphylococcus aureus. | Guerillot R, Goncalves da Silva A, Monk I, Giulieri S, Tomita T, Alison E, Porter J, Pidot S, Gao W, Peleg AY, Seemann T, Stinear TP, Howden BP. | mSphere | 10.1128/msphere.00550-17 | 2018 | |
| Pathogenicity | Molecular epidemiology of heteroresistant vancomycin-intermediate Staphylococcus aureus in Brazil. | Silveira AC, Cunha GR, Caierao J, Cordova CM, d'Azevedo PA. | Braz J Infect Dis | 10.1016/j.bjid.2015.06.013 | 2015 | |
| Enzymology | Longitudinal study of Staphylococcus aureus colonization and infection in a cohort of swine veterinarians in the United States. | Sun J, Yang M, Sreevatsan S, Bender JB, Singer RS, Knutson TP, Marthaler DG, Davies PR. | BMC Infect Dis | 10.1186/s12879-017-2802-1 | 2017 | |
| In vitro vancomycin susceptibility amongst methicillin resistant Staphylococcus aureus. | Chaudhari CN, Tandel K, Grover N, Bhatt P, Sahni AK, Sen S, Prahraj AK. | Med J Armed Forces India | 10.1016/j.mjafi.2013.11.008 | 2014 | | |
| Pathogenicity | Accessory gene regulator (agr) dysfunction in Staphylococcus aureus bloodstream isolates from South Korean patients. | Chong YP, Kim ES, Park SJ, Park KH, Kim T, Kim MN, Kim SH, Lee SO, Choi SH, Woo JH, Jeong JY, Kim YS. | Antimicrob Agents Chemother | 10.1128/aac.01260-12 | 2013 | |
| Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus. | Sirichoat A, Wongthong S, Kanyota R, Tavichakorntrakool R, Chanawong A, Welbat JU, Lulitanond A. | Jundishapur J Microbiol | 10.5812/jjm.26069 | 2016 | | |
| Heterogeneous vancomycin-intermediate among methicillin resistant Staphylococcus aureus. | Chaudhari CN, Tandel K, Grover N, Sen S, Bhatt P, Sahni AK, Praharaj AK. | Med J Armed Forces India | 10.1016/j.mjafi.2014.03.008 | 2015 | | |
| Glycogen synthase kinase 3 inhibition controls Mycobacterium tuberculosis infection. | Pena-Diaz S, Chao JD, Rens C, Haghdadi H, Zheng X, Flanagan K, Ko M, Shapira T, Richter A, Maestre-Batlle D, Canseco JO, Gutierrez MG, Duc KD, Pelech S, Av-Gay Y. | iScience | 10.1016/j.isci.2024.110555 | 2024 | | |
| Pathogenicity | MRSA from Santa Catarina State, Southern Brazil: intriguing epidemiological differences compared to other Brazilian regions. | Silveira AC, Cunha GR, Caierao J, Cordova CM, d'Azevedo PA. | Braz J Infect Dis | 10.1016/j.bjid.2015.04.009 | 2015 | |
| Discovery and Development of 8-Substituted Cycloberberine Derivatives as Novel Antibacterial Agents against MRSA. | Fan T, Hu X, Tang S, Liu X, Wang Y, Deng H, You X, Jiang J, Li Y, Song D. | ACS Med Chem Lett | 10.1021/acsmedchemlett.8b00094 | 2018 | | |
| Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities. | Tripathi AK, Kumari T, Harioudh MK, Yadav PK, Kathuria M, Shukla PK, Mitra K, Ghosh JK. | Sci Rep | 10.1038/s41598-017-03576-1 | 2017 | | |
| Detection of bacterial sulfatase activity through liquid- and solid-phase colony-based assays. | Yoon HY, Kim HJ, Jang S, Hong JI. | AMB Express | 10.1186/s13568-017-0449-3 | 2017 | | |
| In vivo antibacterial activity of MRX-I, a new oxazolidinone. | Li CR, Zhai QQ, Wang XK, Hu XX, Li GQ, Zhang WX, Pang J, Lu X, Yuan H, Gordeev MF, Chen LT, Yang XY, You XF. | Antimicrob Agents Chemother | 10.1128/aac.01526-13 | 2014 | | |
| Pathogenicity | A Novel Microfluidic Assay for Rapid Phenotypic Antibiotic Susceptibility Testing of Bacteria Detected in Clinical Blood Cultures. | Malmberg C, Malmberg C, Yuen P, Spaak J, Cars O, Tangden T, Lagerback P. | PLoS One | 10.1371/journal.pone.0167356 | 2016 | |
| Pathogenicity | Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus: Does Vancomycin Heteroresistance Matter? | Claeys KC, Lagnf AM, Hallesy JA, Compton MT, Gravelin AL, Davis SL, Rybak MJ. | Antimicrob Agents Chemother | 10.1128/aac.02388-15 | 2016 | |
| Pathogenicity | Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey. | Sancak B, Yagci S, Gur D, Gulay Z, Ogunc D, Soyletir G, Yalcin AN, Dundar DO, Topcu AW, Aksit F, Usluer G, Ozakin C, Akalin H, Hayran M, Korten V. | BMC Infect Dis | 10.1186/1471-2334-13-583 | 2013 | |
| Pathogenicity | In Vitro Antibacterial Activity of Rhodanine Derivatives against Pathogenic Clinical Isolates. | AbdelKhalek A, Ashby CR, Patel BA, Talele TT, Seleem MN. | PLoS One | 10.1371/journal.pone.0164227 | 2016 | |
| Antimicrobial activity of seven essential oils from Iranian aromatic plants against common causes of oral infections. | Zomorodian K, Ghadiri P, Saharkhiz MJ, Moein MR, Mehriar P, Bahrani F, Golzar T, Pakshir K, Fani MM. | Jundishapur J Microbiol | 10.5812/jjm.17766 | 2015 | | |
| Pathogenicity | Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA. | Yusof A, Engelhardt A, Karlsson A, Bylund L, Vidh P, Mills K, Wootton M, Walsh TR. | J Clin Microbiol | 10.1128/jcm.00265-08 | 2008 | |
| Pathogenicity | High-Content Screening of Eukaryotic Kinase Inhibitors Identify CHK2 Inhibitor Activity Against Mycobacterium tuberculosis. | Shapira T, Rankine-Wilson L, Chao JD, Pichler V, Rens C, Pfeifer T, Av-Gay Y. | Front Microbiol | 10.3389/fmicb.2020.553962 | 2020 | |
| Pathogenicity | Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays. | Kavanagh A, Ramu S, Gong Y, Cooper MA, Blaskovich MAT. | Antimicrob Agents Chemother | 10.1128/aac.01760-18 | 2019 | |
| Enzymology | Performance of various testing methodologies for detection of heteroresistant vancomycin-intermediate Staphylococcus aureus in bloodstream isolates. | van Hal SJ, Wehrhahn MC, Barbagiannakos T, Mercer J, Chen D, Paterson DL, Gosbell IB. | J Clin Microbiol | 10.1128/jcm.02302-10 | 2011 | |
| Antibiotics Development and the Potentials of Marine-Derived Compounds to Stem the Tide of Multidrug-Resistant Pathogenic Bacteria, Fungi, and Protozoa. | Nweze JA, Mbaoji FN, Huang G, Li Y, Yang L, Zhang Y, Huang S, Pan L, Yang D. | Mar Drugs | 10.3390/md18030145 | 2020 | | |
| Pathogenicity | Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections. | Holmes NE, Johnson PD, Howden BP. | J Clin Microbiol | 10.1128/jcm.00775-12 | 2012 | |
| Clinical and microbiologic analysis of the risk factors for mortality in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia. | Chong YP, Park KH, Kim ES, Kim MN, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Kim YS. | Antimicrob Agents Chemother | 10.1128/aac.04765-14 | 2015 | | |
| Pathogenicity | Antimicrobial, antiparasitic, anti-inflammatory, and cytotoxic activities of Lopezia racemosa. | Cruz Paredes C, Bolivar Balbas P, Gomez-Velasco A, Juarez ZN, Sanchez Arreola E, Hernandez LR, Bach H. | ScientificWorldJournal | 10.1155/2013/237438 | 2013 | |
| Pathogenicity | Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. | Howden BP, Johnson PD, Ward PB, Stinear TP, Davies JK. | Antimicrob Agents Chemother | 10.1128/aac.00422-06 | 2006 | |
| Piscidin-1-analogs with double L- and D-lysine residues exhibited different conformations in lipopolysaccharide but comparable anti-endotoxin activities. | Kumar A, Kumar A, Mahajan M, Awasthi B, Tandon A, Harioudh MK, Shree S, Singh P, Shukla PK, Ramachandran R, Mitra K, Bhattacharjya S, Ghosh JK. | Sci Rep | 10.1038/srep39925 | 2017 | | |
| Pathogenicity | Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus. | Fitzgibbon MM, Rossney AS, O'Connell B. | J Clin Microbiol | 10.1128/jcm.00836-07 | 2007 | |
| Pathogenicity | Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center. | Kosowska-Shick K, Ednie LM, McGhee P, Smith K, Todd CD, Wehler A, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.01073-08 | 2008 | |
| Pathogenicity | Health care-associated endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin. | Chi CY, Lauderdale TL, Wang SM, Wu JM, Yang YJ, Liu CC. | J Clin Microbiol | 10.1128/jcm.01004-07 | 2008 | |
| Clinical Outcomes in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bloodstream Infection. | Casapao AM, Leonard SN, Davis SL, Lodise TP, Patel N, Goff DA, LaPlante KL, Potoski BA, Rybak MJ. | Antimicrob Agents Chemother | 10.1128/aac.00380-13 | 2013 | | |
| Metabolism | Comparative Prevalence of Immune Evasion Complex Genes Associated with beta-Hemolysin Converting Bacteriophages in MRSA ST5 Isolates from Swine, Swine Facilities, Humans with Swine Contact, and Humans with No Swine Contact. | Hau SJ, Sun J, Davies PR, Frana TS, Nicholson TL. | PLoS One | 10.1371/journal.pone.0142832 | 2015 | |
| Metabolism | Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypes. | Ythier M, Resch G, Waridel P, Panchaud A, Gfeller A, Majcherczyk P, Quadroni M, Moreillon P. | Mol Cell Proteomics | 10.1074/mcp.m111.014191 | 2012 | |
| Micropatterned Endotracheal Tubes Reduce Secretion-Related Lumen Occlusion. | Mann EE, Magin CM, Mettetal MR, May RM, Henry MM, DeLoid H, Prater J, Sullivan L, Thomas JG, Twite MD, Parker AE, Brennan AB, Reddy ST. | Ann Biomed Eng | 10.1007/s10439-016-1698-z | 2016 | | |
| Enzymology | Persistent catheter-related Staphylococcus aureus bacteremia after catheter removal and initiation of antimicrobial therapy. | Park KH, Lee YM, Hong HL, Kim T, Park HJ, Park SY, Moon SM, Chong YP, Kim SH, Lee SO, Choi SH, Jeong JY, Kim MN, Woo JH, Kim YS. | PLoS One | 10.1371/journal.pone.0046389 | 2012 | |
| Pathogenicity | Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006. | Adam HJ, Louie L, Watt C, Gravel D, Bryce E, Loeb M, Matlow A, McGeer A, Mulvey MR, Simor AE, Canadian Nosocomial Infection Surveillance Program. | Antimicrob Agents Chemother | 10.1128/aac.01316-09 | 2010 | |
| Pathogenicity | Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates. | Pitz AM, Yu F, Hermsen ED, Rupp ME, Fey PD, Olsen KM. | J Clin Microbiol | 10.1128/jcm.00914-10 | 2011 | |
| Pathogenicity | Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China. | Hu J, Ma XX, Tian Y, Pang L, Cui LZ, Shang H. | PLoS One | 10.1371/journal.pone.0073300 | 2013 | |
| Antimicrobial, anti-inflammatory, antiparasitic, and cytotoxic activities of Laennecia confusa. | Martinez Ruiz MG, Richard-Greenblatt M, Juarez ZN, Av-Gay Y, Bach H, Hernandez LR. | ScientificWorldJournal | 10.1100/2012/263572 | 2012 | | |
| Pathogenicity | Inactivation of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE) on various environmental surfaces by mist application of a stabilized chlorine dioxide and quaternary ammonium compound-based disinfectant. | Callahan KL, Beck NK, Duffield EA, Shin G, Meschke JS. | J Occup Environ Hyg | 10.1080/15459624.2010.487806 | 2010 | |
| Chemical composition and antimicrobial activities of essential oil of nepeta cataria L. Against common causes of oral infections. | Zomorodian K, Saharkhiz MJ, Rahimi MJ, Shariatifard S, Pakshir K, Khashei R. | J Dent (Tehran) | 2013 | | ||
| Pathogenicity | Vancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcus aureus blood stream infections. | van Hal SJ, Jones M, Gosbell IB, Paterson DL. | PLoS One | 10.1371/journal.pone.0021217 | 2011 | |
| Pathogenicity | Vancomycin heteroresistance in bloodstream isolates of Staphylococcus capitis. | D'mello D, Daley AJ, Rahman MS, Qu Y, Garland S, Pearce C, Deighton MA. | J Clin Microbiol | 10.1128/jcm.00592-08 | 2008 | |
| Genetics | An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection. | Miller CE, Batra R, Cooper BS, Patel AK, Klein J, Otter JA, Kypraios T, French GL, Tosas O, Edgeworth JD. | Clin Infect Dis | 10.1093/cid/cir858 | 2012 | |
| Pathogenicity | The first vancomycin-intermediate Staphylococcus aureus strains isolated from patients in Thailand. | Lulitanond A, Engchanil C, Chaimanee P, Vorachit M, Ito T, Hiramatsu K. | J Clin Microbiol | 10.1128/jcm.01749-08 | 2009 | |
| Phylogeny | SmaI restriction site-based multiplex PCR for typing of hospital- and community-acquired Staphylococcus aureus. | Al-Zahrani IA, Hamson C, Edge D, Collins J, Perry JD, Raza M, Gould K, Harwood CR. | J Clin Microbiol | 10.1128/jcm.00857-11 | 2011 | |
| Enzymology | Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin. | Welsh KJ, Abbott AN, Lewis EM, Gardiner JM, Kruzel MC, Lewis CT, Mohr JF, Wanger A, Armitige LY. | J Clin Microbiol | 10.1128/jcm.01949-09 | 2010 | |
| Pathogenicity | In vitro activity of the new quinolone WCK 771 against staphylococci. | Jacobs MR, Bajaksouzian S, Windau A, Appelbaum PC, Patel MV, Gupte SV, Bhagwat SS, De Souza NJ, Khorakiwala HF. | Antimicrob Agents Chemother | 10.1128/aac.48.9.3338-3342.2004 | 2004 | |
| Pathogenicity | Metal nanoparticles: understanding the mechanisms behind antibacterial activity. | Slavin YN, Asnis J, Hafeli UO, Bach H. | J Nanobiotechnology | 10.1186/s12951-017-0308-z | 2017 | |
| Pathogenicity | Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis. | Lee JYH, Monk IR, Goncalves da Silva A, Seemann T, Chua KYL, Kearns A, Hill R, Woodford N, Bartels MD, Strommenger B, Laurent F, Dodemont M, Deplano A, Patel R, Larsen AR, Korman TM, Stinear TP, Howden BP. | Nat Microbiol | 10.1038/s41564-018-0230-7 | 2018 | |
| Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance. | Bae IG, Federspiel JJ, Miro JM, Woods CW, Park L, Rybak MJ, Rude TH, Bradley S, Bukovski S, de la Maria CG, Kanj SS, Korman TM, Marco F, Murdoch DR, Plesiat P, Rodriguez-Creixems M, Reinbott P, Steed L, Tattevin P, Tripodi MF, Newton KL, Corey GR, Fowler VG, International Collaboration on Endocarditis-Microbiology Investigator. | J Infect Dis | 10.1086/606027 | 2009 | | |
| Pathogenicity | Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II. | Lunde CS, Hartouni SR, Janc JW, Mammen M, Humphrey PP, Benton BM. | Antimicrob Agents Chemother | 10.1128/aac.01710-08 | 2009 | |
| Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. | Reyes J, Rincon S, Diaz L, Panesso D, Contreras GA, Zurita J, Carrillo C, Rizzi A, Guzman M, Adachi J, Chowdhury S, Murray BE, Arias CA. | Clin Infect Dis | 10.1086/648426 | 2009 | | |
| Countrywide molecular survey of methicillin-resistant Staphylococcus aureus strains in Poland. | Luczak-Kadlubowska A, Sulikowska A, Empel J, Piasecka A, Orczykowska M, Kozinska A, Hryniewicz W. | J Clin Microbiol | 10.1128/jcm.00869-08 | 2008 | | |
| Pathogenicity | Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus. | Kusuma CM, Kokai-Kun JF. | Antimicrob Agents Chemother | 10.1128/aac.49.8.3256-3263.2005 | 2005 | |
| Pathogenicity | Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus. | Vaudaux P, Huggler E, Bernard L, Ferry T, Renzoni A, Lew DP. | Antimicrob Agents Chemother | 10.1128/aac.00269-10 | 2010 | |
| Chemical composition and antimicrobial activities of the essential oils from three ecotypes of Zataria multiflora. | Zomorodian K, Saharkhiz MJ, Rahimi MJ, Bandegi A, Shekarkhar G, Bandegani A, Pakshir K, Bazargani A. | Pharmacogn Mag | 10.4103/0973-1296.75902 | 2011 | | |
| Genetics | Functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 Staphylococcus epidermidis. | Lee JYH, Monk IR, Pidot SJ, Singh S, Chua KYL, Seemann T, Stinear TP, Howden BP. | Microb Genom | 10.1099/mgen.0.000077 | 2016 | |
| Pathogenicity | Pharmacokinetic/pharmacodynamic factors influencing emergence of resistance to linezolid in an in vitro model. | Boak LM, Li J, Rayner CR, Nation RL. | Antimicrob Agents Chemother | 10.1128/aac.01194-06 | 2007 | |
| Phylogeny | Characteristics of Staphylococcus aureus strains isolated in Poland in 1996 to 2004 that were deficient in species-specific proteins. | Luczak-Kadlubowska A, Krzyszton-Russjan J, Hryniewicz W. | J Clin Microbiol | 10.1128/jcm.01164-06 | 2006 | |
| Pathogenicity | High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in The Netherlands. | Van Griethuysen A, Van 't Veen A, Buiting A, Walsh T, Kluytmans J. | J Clin Microbiol | 10.1128/jcm.41.6.2487-2491.2003 | 2003 | |
| Pathogenicity | Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. | Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. | Clin Microbiol Rev | 10.1128/cmr.00042-09 | 2010 | |
| Phylogeny | The emergence and importation of diverse genotypes of methicillin-resistant Staphylococcus aureus (MRSA) harboring the Panton-Valentine leukocidin gene (pvl) reveal that pvl is a poor marker for community-acquired MRSA strains in Ireland. | Rossney AS, Shore AC, Morgan PM, Fitzgibbon MM, O'Connell B, Coleman DC. | J Clin Microbiol | 10.1128/jcm.00245-07 | 2007 | |
| Pathogenicity | Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis. | Garcia-de-la-Maria C, Marco F, Armero Y, Soy D, Moreno A, del Rio A, Almela M, Cervera C, Ninot S, Falces C, Mestres CA, Gatell JM, Jimenez de Anta MT, Miro JM, Hospital Clinic Experimental Endocarditis Study Group. | Antimicrob Agents Chemother | 10.1128/aac.01011-09 | 2010 | |
| Pathogenicity | NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strains. | Li Q, Lee JY, Castillo R, Hixon MS, Pujol C, Doppalapudi VR, Shepard HM, Wahl GM, Lobl TJ, Chan MF. | Antimicrob Agents Chemother | 10.1128/aac.46.5.1262-1268.2002 | 2002 | |
| Integrated assessment of mucilage impact on human health using the One Health approach: Prevalence and antimicrobial resistance profiles of Escherichia coli and Clostridium perfringens in the Marmara Sea, Türkiye. | Yibar A, Ay H, Aydin F, Abay S, Karakaya E, Kayman T, Dalyan C, Koca FD, Aydogdu D, Ajmi N, Duman M, Saticioglu IB. | Heliyon | 10.1016/j.heliyon.2025.e42103 | 2025 | | |
| Identification of antibacterial constituents from Rhododendron simsii Planch with an activity-guided method. | Lai Y, Zhong YT, Liang Y, Chen WC, Liao Q, Li M, Han P, Cai YS, Wang F. | Front Pharmacol | 10.3389/fphar.2024.1490335 | 2024 | | |
| Surgical therapy and outcome of descending necrotizing mediastinitis in Chinese: a single-center series. | Zhao Z, Ma D, Xu Y, Guo C, Li S, Wang J, Wang M, Qin Y, Liu H. | Front Med (Lausanne) | 10.3389/fmed.2023.1337852 | 2023 | | |
| Marjolin's ulcer in an ischial pressure sore presented with necrotizing soft tissue infection: A case report. | Huang CY, Hsieh ZY, Chang KC, Chang DH. | Medicine (Baltimore) | 10.1097/md.0000000000033450 | 2023 | | |
| Metabolism | Rational Design and Experimental Analysis of Short-Oligonucleotide Substrate Specificity for Targeting Bacterial Nucleases. | Jimenez T, Botero J, Otaegui D, Calvo J, Hernandez FJ, San Sebastian E. | J Med Chem | 10.1021/acs.jmedchem.1c00884 | 2021 | |
| Risk of infections among persons treated with opioids for chronic pain: a systematic review and meta-analysis protocol. | Kudrina I, Page MG, Choiniere M, Shir Y, Eisenberg MJ, Ben-Sasson M, Lebouche B, Puzhko S. | BMJ Open | 10.1136/bmjopen-2023-083791 | 2024 | | |
| Transcriptome | Rumen microbiota-host transcriptome interaction mediates the protective effects of trans-10, cis-12 CLA on facilitating weaning transition of lambs. | Yang C, Deng X, Lund P, Liu H, Ding X, Fu Z, Zhang N, Li J, Dong L. | Anim Nutr | 10.1016/j.aninu.2022.11.002 | 2023 | |
| High-Throughput Screening of the Repurposing Hub Library to Identify Drugs with Novel Inhibitory Activity against Candida albicans and Candida auris Biofilms. | Ajetunmobi OH, Wall G, Vidal Bonifacio B, Martinez Delgado LA, Chaturvedi AK, Najvar LK, Wormley FL, Patterson HP, Wiederhold NP, Patterson TF, Lopez-Ribot JL. | J Fungi (Basel) | 10.3390/jof9090879 | 2023 | | |
| Designing phage cocktails to combat the emergence of bacteriophage-resistant mutants in multidrug-resistant Klebsiella pneumoniae. | Yoo S, Lee K-M, Kim N, Vu TN, Abadie R, Yong D. | Microbiol Spectr | 10.1128/spectrum.01258-23 | 2024 | | |
| Pathogenicity | Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study. | Martirosov DM, Bidell MR, Pai MP, Scheetz MH, Rosenkranz SL, Faragon C, Malik M, Mendes RE, Jones RN, McNutt LA, Lodise TP. | BMC Infect Dis | 10.1186/s12879-017-2609-0 | 2017 | |
| Mucosal Immunity in Cystic Fibrosis. | Bojanowski CM, Lu S, Kolls JK. | J Immunol | 10.4049/jimmunol.2100424 | 2021 | | |
| Prevalence, Genetic Diversity, Antimicrobial Resistance, and Toxigenic Profile of Vibrio vulnificus Isolated from Aquatic Environments in Taiwan. | Lin IC, Hussain B, Hsu BM, Chen JS, Hsu YL, Chiu YC, Huang SW, Wang JL. | Antibiotics (Basel) | 10.3390/antibiotics10050505 | 2021 | | |
| Protein moonlighting: what is it, and why is it important? | Jeffery CJ. | Philos Trans R Soc Lond B Biol Sci | 10.1098/rstb.2016.0523 | 2018 | | |
| Antibiotic sensitivity profile of bacterial pathogens in postoperative wound infections at a tertiary care hospital in Gujarat, India. | Goswami NN, Trivedi HR, Goswami AP, Patel TK, Tripathi CB. | J Pharmacol Pharmacother | 10.4103/0976-500x.83279 | 2011 | | |
| Pathogenicity | Triple combinations of lower and longer alkyl gallates and oxacillin improve antibiotic synergy against methicillin-resistant Staphylococcus aureus. | Shibata H, Nakano T, Parvez MA, Furukawa Y, Tomoishi A, Niimi S, Arakaki N, Higuti T. | Antimicrob Agents Chemother | 10.1128/aac.00829-08 | 2009 | |
| Characterization of a mouse-adapted Staphylococcus aureus strain. | Holtfreter S, Radcliff FJ, Grumann D, Read H, Johnson S, Monecke S, Ritchie S, Clow F, Goerke C, Broker BM, Fraser JD, Wiles S. | PLoS One | 10.1371/journal.pone.0071142 | 2013 | | |
| Transcriptome | A Transcriptomic Response to Lactiplantibacillus plantarum-KCC48 against High-Fat Diet-Induced Fatty Liver Diseases in Mice. | Soundharrajan I, Karnan M, Jung JS, Lee KD, Lee JC, Ramesh T, Kim D, Choi KC. | Int J Mol Sci | 10.3390/ijms23126750 | 2022 | |
| Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients. | Maor Y, Lago L, Zlotkin A, Nitzan Y, Belausov N, Ben-David D, Keller N, Rahav G. | BMC Microbiol | 10.1186/1471-2180-9-189 | 2009 | | |
| Pathogenicity | Application of Force to a Syndecan-4 Containing Complex With Thy-1-alphaVbeta3 Integrin Accelerates Neurite Retraction. | Burgos-Bravo F, Martinez-Meza S, Quest AFG, Wilson CAM, Leyton L. | Front Mol Biosci | 10.3389/fmolb.2020.582257 | 2020 | |
| Pathogenicity | [Epidemiological investigation of "beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)"]. | Hanaki H, Yamaguchi Y. | Kansenshogaku Zasshi | 10.11150/kansenshogakuzasshi1970.77.499 | 2003 | |
| Interventions for cellulitis and erysipelas. | Kilburn SA, Featherstone P, Higgins B, Brindle R. | Cochrane Database Syst Rev | 10.1002/14651858.cd004299.pub2 | 2010 | | |
| Metabolism | Dysregulated mitochondrial and chloroplast bioenergetics from a translational medical perspective (Review). | Stefano GB, Kream RM. | Int J Mol Med | 10.3892/ijmm.2016.2471 | 2016 | |
| Lysine deacetylase inhibition promotes relaxation of arterial tone and C-terminal acetylation of HSPB6 (Hsp20) in vascular smooth muscle cells. | Chen A, Karolczak-Bayatti M, Sweeney M, Treumann A, Morrissey K, Ulrich SM, Europe-Finner GN, Taggart MJ. | Physiol Rep | 10.1002/phy2.127 | 2013 | | |
| DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis. | Magalhaes M, Rivals I, Claustres M, Varilh J, Thomasset M, Bergougnoux A, Mely L, Leroy S, Corvol H, Guillot L, Murris M, Beyne E, Caimmi D, Vachier I, Chiron R, De Sario A. | Clin Epigenetics | 10.1186/s13148-016-0300-8 | 2017 | | |
| Pathogenicity | Rice bran feruloylated oligosaccharides activate dendritic cells via Toll-like receptor 2 and 4 signaling. | Lin CC, Chen HH, Chen YK, Chang HC, Lin PY, Pan IH, Chen DY, Chen CM, Lin SY. | Molecules | 10.3390/molecules19045325 | 2014 | |
| Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models. | Patel MV, De Souza NJ, Gupte SV, Jafri MA, Bhagwat SS, Chugh Y, Khorakiwala HF, Jacobs MR, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.48.12.4754-4761.2004 | 2004 | | |
| Pathogenicity | Escherichia coli resistance to nonbiocidal antibiofilm polysaccharides is rare and mediated by multiple mutations leading to surface physicochemical modifications. | Travier L, Rendueles O, Ferrieres L, Herry JM, Ghigo JM. | Antimicrob Agents Chemother | 10.1128/aac.02606-12 | 2013 | |
| Relationship of somatic cell count and cell volume analysis of goat's milk to intramammary infection with coagulase-negative staphylococci. | Sheldrake RF, Hoare RJ, Woodhouse VE. | J Dairy Res | 10.1017/s0022029900021877 | 1981 | | |
| Metabolism | Effects of DU-6859a, a new quinolone antimicrobial, on theophylline metabolism in in vitro and in vivo studies. | Niki Y, Itokawa K, Okazaki O. | Antimicrob Agents Chemother | 10.1128/aac.42.7.1751 | 1998 | |
| Metabolism | Tn552 transposase catalyzes concerted strand transfer in vitro. | Leschziner AE, Griffin TJ, Grindley ND. | Proc Natl Acad Sci U S A | 10.1073/pnas.95.13.7345 | 1998 | |
| Clinical laboratory comparison of lysis-centrifugation and BACTEC radiometric blood culture techniques. | McLaughlin JC, Hamilton P, Scholes JV, Bartlett RC. | J Clin Microbiol | 10.1128/jcm.18.5.1027-1031.1983 | 1983 | | |
| Pathogenicity | Efficacy and mechanism of carvacrol with octanoic acid against mastitis causing multi-drug-resistant pathogens. | Rani S, Singh H, Ram C | Braz J Microbiol | 10.1007/s42770-021-00639-4 | 2021 | |
| Phenotype | Variable Release of Lipoteichoic Acid From Staphylococcus aureus Bloodstream Isolates Relates to Distinct Clinical Phenotypes, Strain Background, and Antibiotic Exposure. | Algorri M, Jorth P, Wong-Beringer A | Front Microbiol | 10.3389/fmicb.2020.609280 | 2021 | |
| Pathogenicity | Differentiation of qacA and qacB using high-resolution melt curve analysis, and both qacA and qacB but not qacC or norA types increase chlorhexidine minimal inhibitory concentrations in Staphylococcus aureus isolates. | Lin KH, Lin CY, Huang CC, Ho YL, Yang SF, Ho CM | J Microbiol Immunol Infect | 10.1016/j.jmii.2020.09.006 | 2020 | |
| Enzymology | Comparison of In Vivo Pharmacokinetics and Pharmacodynamics of Vancomycin Products Available in Korea. | Kim HK, Choi SM, Kang G, Park KH, Lee DG, Park WB, Rhee SJ, Lee S, Jung SI, Jang HC | Yonsei Med J | 10.3349/ymj.2020.61.4.301 | 2020 | |
| Pathogenicity | Protective activity of anti-lipoteichoic acid monoclonal antibody in single or combination therapies in methicillin-resistant Staphylococcus aureus-induced murine sepsis models. | Ohsawa H, Baba T, Enami J, Hiramatsu K | J Infect Chemother | 10.1016/j.jiac.2019.12.018 | 2020 | |
| Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Uses the VraSR Regulatory System to Modulate Autophagy for Increased Intracellular Survival in Macrophage-Like Cell Line RAW264.7. | Dai Y, Gao C, Chen L, Chang W, Yu W, Ma X, Li J | Front Microbiol | 10.3389/fmicb.2019.01222 | 2019 | | |
| Pathogenicity | VraSR has an important role in immune evasion of Staphylococcus aureus with low level vancomycin resistance. | Gao C, Dai Y, Chang W, Fang C, Wang Z, Ma X | Microbes Infect | 10.1016/j.micinf.2019.04.003 | 2019 | |
| Pathogenicity | Identification of a Novel Gene Associated with High-Level beta-Lactam Resistance in Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Strain Mu3 and Methicillin-Resistant S. aureus Strain N315. | Matsuo M, Yamamoto N, Hishinuma T, Hiramatsu K | Antimicrob Agents Chemother | 10.1128/AAC.00712-18 | 2019 | |
| Pathogenicity | Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus. | Zheng X, Berti AD, McCrone S, Roch M, Rosato AE, Rose WE, Chen B | Antimicrob Agents Chemother | 10.1128/AAC.02100-17 | 2018 | |
| Pathogenicity | Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus. | Katayama Y, Azechi T, Miyazaki M, Takata T, Sekine M, Matsui H, Hanaki H, Yahara K, Sasano H, Asakura K, Takaku T, Ochiai T, Komatsu N, Chambers HF | Antimicrob Agents Chemother | 10.1128/AAC.00452-17 | 2017 | |
| Pathogenicity | VraR Binding to the Promoter Region of agr Inhibits Its Function in Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA. | Dai Y, Chang W, Zhao C, Peng J, Xu L, Lu H, Zhou S, Ma X | Antimicrob Agents Chemother | 10.1128/AAC.02740-16 | 2017 | |
| Pathogenicity | Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA. | Lai CC, Chen CC, Chuang YC, Tang HJ | Sci Rep | 10.1038/srep41758 | 2017 | |
| Transcriptome | Complete sequence of a plasmid from a bovine methicillin-resistant Staphylococcus aureus harbouring a novel ica-like gene cluster in addition to antimicrobial and heavy metal resistance genes. | Fessler AT, Zhao Q, Schoenfelder S, Kadlec K, Brenner Michael G, Wang Y, Ziebuhr W, Shen J, Schwarz S | Vet Microbiol | 10.1016/j.vetmic.2016.07.010 | 2016 | |
| Metabolism | Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus. | Katayama Y, Sekine M, Hishinuma T, Aiba Y, Hiramatsu K | Antimicrob Agents Chemother | 10.1128/AAC.00420-16 | 2016 | |
| Pathogenicity | Screening for Intermediately Vancomycin-Susceptible and Vancomycin-Heteroresistant Staphylococcus aureus by Use of Vancomycin-Supplemented Brain Heart Infusion Agar Biplates: Defining Growth Interpretation Criteria Based on Gold Standard Confirmation. | Khatib R, Riederer K, Sharma M, Shemes S, Iyer SP, Szpunar S | J Clin Microbiol | 10.1128/JCM.01620-15 | 2015 | |
| Pathogenicity | Adaptation to vancomycin pressure of multiresistant Staphylococcus capitis NRCS-A involved in neonatal sepsis. | Butin M, Martins-Simoes P, Picaud JC, Kearns A, Claris O, Vandenesch F, Laurent F, Rasigade JP | J Antimicrob Chemother | 10.1093/jac/dkv217 | 2015 | |
| Pathogenicity | Exposure of Staphylococcus aureus to subinhibitory concentrations of beta-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus. | Roch M, Clair P, Renzoni A, Reverdy ME, Dauwalder O, Bes M, Martra A, Freydiere AM, Laurent F, Reix P, Dumitrescu O, Vandenesch F | Antimicrob Agents Chemother | 10.1128/AAC.02574-14 | 2014 | |
| Phenotype | "Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3. | Saito M, Katayama Y, Hishinuma T, Iwamoto A, Aiba Y, Kuwahara-Arai K, Cui L, Matsuo M, Aritaka N, Hiramatsu K | Antimicrob Agents Chemother | 10.1128/AAC.02470-13 | 2014 | |
| Pathogenicity | Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3. | Matsuo M, Cui L, Kim J, Hiramatsu K | Antimicrob Agents Chemother | 10.1128/AAC.00425-13 | 2013 | |
| Phylogeny | Global analysis of transcriptional regulators in Staphylococcus aureus. | Ibarra JA, Perez-Rueda E, Carroll RK, Shaw LN | BMC Genomics | 10.1186/1471-2164-14-126 | 2013 | |
| Phenotype | Presence of both heterogeneous vancomycin-intermediate resistance and beta-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection. | Takata T, Miyazaki M, Futo M, Hara S, Shiotsuka S, Kamimura H, Yoshimura H, Matsunaga A, Nishida T, Ishikura H, Ishikawa T, Tamura K, Tsuji BT | Scand J Infect Dis | 10.3109/00365548.2012.723221 | 2012 | |
| Pathogenicity | Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3. | Matsuo M, Hishinuma T, Katayama Y, Cui L, Kapi M, Hiramatsu K | Antimicrob Agents Chemother | 10.1128/AAC.00398-11 | 2011 | |
| Phylogeny | Sequence diversities of serine-aspartate repeat genes among Staphylococcus aureus isolates from different hosts presumably by horizontal gene transfer. | Xue H, Lu H, Zhao X | PLoS One | 10.1371/journal.pone.0020332 | 2011 | |
| Pathogenicity | Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia. | Khatib R, Jose J, Musta A, Sharma M, Fakih MG, Johnson LB, Riederer K, Shemes S | J Antimicrob Chemother | 10.1093/jac/dkr169 | 2011 | |
| Pathogenicity | Detection of intermediately vancomycin-susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and Agar screening methods. | Riederer K, Shemes S, Chase P, Musta A, Mar A, Khatib R | J Clin Microbiol | 10.1128/JCM.01435-10 | 2011 | |
| Pathogenicity | Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. | Satola SW, Farley MM, Anderson KF, Patel JB | J Clin Microbiol | 10.1128/JCM.01128-10 | 2010 | |
| Pathogenicity | First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia. | Al-Obeid S, Haddad Q, Cherkaoui A, Schrenzel J, Francois P | J Clin Microbiol | 10.1128/JCM.00954-09 | 2010 | |
| Pathogenicity | Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia. | Hegde SS, Skinner R, Lewis SR, Krause KM, Blais J, Benton BM | J Antimicrob Chemother | 10.1093/jac/dkq028 | 2010 | |
| Pathogenicity | Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. | Horne KC, Howden BP, Grabsch EA, Graham M, Ward PB, Xie S, Mayall BC, Johnson PD, Grayson ML | Antimicrob Agents Chemother | 10.1128/AAC.01365-08 | 2009 | |
| Genetics | Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem. | Katayama Y, Murakami-Kuroda H, Cui L, Hiramatsu K | Antimicrob Agents Chemother | 10.1128/AAC.00834-08 | 2009 | |
| Pathogenicity | Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model. | Hegde SS, Difuntorum S, Skinner R, Trumbull J, Krause KM | J Antimicrob Chemother | 10.1093/jac/dkp001 | 2009 | |
| Enzymology | Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations. | Leonard SN, Rybak MJ | J Antimicrob Chemother | 10.1093/jac/dkn439 | 2008 | |
| Pathogenicity | Modified PAP method to detect heteroresistance to vancomycin among methicillin resistant Staphylococcus aureus isolates at a tertiary care hospital. | Iyer RN, Hittinahalli V | Indian J Med Microbiol | 10.4103/0255-0857.40537 | 2008 | |
| Pathogenicity | The antagonistic effects of a combination of vancomycin and minocycline in Staphylococcus aureus with heterogeneous resistance to vancomycin. | Oshiro T, Nagasawa Z, Hanaki H, Ikeda-Dantsuji Y, Nagayama A | J Infect Chemother | 10.1007/s10156-007-0569-9 | 2008 | |
| Pathogenicity | Evaluation of Fourier transform infrared spectroscopy for the rapid identification of glycopeptide-intermediate Staphylococcus aureus. | Amiali NM, Mulvey MR, Berger-Bachi B, Sedman J, Simor AE, Ismail AA | J Antimicrob Chemother | 10.1093/jac/dkm400 | 2007 | |
| Pathogenicity | Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance. | Neoh HM, Cui L, Yuzawa H, Takeuchi F, Matsuo M, Hiramatsu K | Antimicrob Agents Chemother | 10.1128/AAC.00534-07 | 2007 | |
| Pathogenicity | Autolytic properties of glycopeptide-intermediate Staphylococcus aureus Mu50. | Utaida S, Pfeltz RF, Jayaswal RK, Wilkinson BJ | Antimicrob Agents Chemother | 10.1128/AAC.50.4.1541-1545.2006 | 2006 | |
| Pathogenicity | [The combined effect of methicillin and teicoplanin against Staphylococcus aureus strains investigated in vitro]. | Mlynarczyk A, Mlynarczyk G, Luczak M | Med Dosw Mikrobiol | 2005 | | |
| Transcriptome | A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. | McAleese F, Petersen P, Ruzin A, Dunman PM, Murphy E, Projan SJ, Bradford PA | Antimicrob Agents Chemother | 10.1128/AAC.49.5.1865-1871.2005 | 2005 | |
| Pathogenicity | Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals. | Nonhoff C, Denis O, Struelens MJ | Clin Microbiol Infect | 10.1111/j.1469-0691.2004.01060.x | 2005 | |
| Pathogenicity | In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci. | Bergeret M, Boutros N, Raymond J | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2003.08.009 | 2004 | |
| Metabolism | Nucleotide substitutions in Staphylococcus aureus strains, Mu50, Mu3, and N315. | Ohta T, Hirakawa H, Morikawa K, Maruyama A, Inose Y, Yamashita A, Oshima K, Kuroda M, Hattori M, Hiramatsu K, Kuhara S, Hayashi H | DNA Res | 10.1093/dnares/11.1.51 | 2004 | |
| Pathogenicity | [Epidemiological investigation of MRSA with antagonistic effects of beta-lactam antibiotic and vancomycin]. | Yamaguchi Y, Hanaki H, Barada K, Inamatu T, Sunakawa K | Kansenshogaku Zasshi | 10.11150/kansenshogakuzasshi1970.77.661 | 2003 | |
| Pathogenicity | Efficacy of vancomycin-beta-lactam combinations against heterogeneously vancomycin-resistant Staphylococcus aureus (hetero-VRSA). | Kim YS, Kiem S, Yun HJ, Jung SI, Oh WS, Kim SW, Peck KR, Lee NY, Song JH | J Korean Med Sci | 10.3346/jkms.2003.18.3.319 | 2003 | |
| Pathogenicity | Emergence of vancomycin resistance during therapy against methicillin-resistant Staphylococcus aureus in a burn patient--importance of low-level resistance to vancomycin. | Haraga I, Nomura S, Fukamachi S, Ohjimi H, Hanaki H, Hiramatsu K, Nagayama A | Int J Infect Dis | 10.1016/s1201-9712(02)90165-7 | 2002 | |
| Pathogenicity | Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals. | Ike Y, Arakawa Y, Ma X, Tatewaki K, Nagasawa M, Tomita H, Tanimoto K, Fujimoto S | J Clin Microbiol | 10.1128/JCM.39.12.4445-4451.2001 | 2001 | |
| Pathogenicity | [Investigation of infective endocarditis clinical isolates of methicillin resistant Staphylococcus aureus non-responsive to vancomycin]. | Takayama Y, Yoshida K, Yamaguchi Y, Nonoyama M, Endo T, Sunakawa K | Kansenshogaku Zasshi | 10.11150/kansenshogakuzasshi1970.75.473 | 2001 | |
| Pathogenicity | Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. | Walsh TR, Bolmstrom A, Qwarnstrom A, Ho P, Wootton M, Howe RA, MacGowan AP, Diekema D | J Clin Microbiol | 10.1128/JCM.39.7.2439-2444.2001 | 2001 | |
| Pathogenicity | [Clinical relevance of hetero-VRSA in surgical infections]. | Okii K, Takesue Y, Yokoyama T | Nihon Rinsho | 2001 | | |
| Pathogenicity | A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. | Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, MacGowan AP | J Antimicrob Chemother | 10.1093/jac/47.4.399 | 2001 | |
| Pathogenicity | Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin. | Aritaka N, Hanaki H, Cui L, Hiramatsu K | Antimicrob Agents Chemother | 10.1128/AAC.45.4.1292-1294.2001 | 2001 | |
| Detection Methods for Glycopeptide-Resistant Staphylococcus aureus II : Cell Wall Analysis. | Hanaki H, Hiramatsu K | Methods Mol Med | 10.1385/1-59259-077-2:93 | 2001 | | |
| Detection Methods of Glycopeptide-Resistant Staphylococcus aureus I : Susceptibility Testing. | Hanaki H, Hiramatsu K | Methods Mol Med | 10.1385/1-59259-077-2:85 | 2001 | | |
| Metabolism | A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates. | Boyle-Vavra S, Labischinski H, Ebert CC, Ehlert K, Daum RS | Antimicrob Agents Chemother | 10.1128/AAC.45.1.280-287.2001 | 2001 | |
| Phylogeny | Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method. | Kuroda M, Kuwahara-Arai K, Hiramatsu K | Biochem Biophys Res Commun | 10.1006/bbrc.2000.2277 | 2000 | |
| Cultivation | [A novel method of detecting Staphylococcus aureus heterogeneously resistant to vancomycin (hetero-VRSA)]. | Hanaki H, Inaba Y, Sasaki K, Hiramatsu K | Jpn J Antibiot | 1998 | | |
| Metabolism | Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50. | Hanaki H, Labischinski H, Inaba Y, Kondo N, Murakami H, Hiramatsu K | J Antimicrob Chemother | 10.1093/jac/42.3.315 | 1998 | |
| Metabolism | Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. | Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K | J Antimicrob Chemother | 10.1093/jac/42.2.199 | 1998 | |
| Pathogenicity | The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan. | Hiramatsu K | Am J Med | 10.1016/s0002-9343(98)00149-1 | 1998 | |
| Pathogenicity | Heterogeneous vancomycin resistance in Staphylococcus aureus does not predict development of vancomycin resistance upon vancomycin pressure. | Gaillard T, Dupieux-Chabert C, Butin M, Dumitrescu O, Naceur O, Bouveyron C, Martra A, Bes M, Tristan A, Vandenesch F, Lina G, Laurent F, Rasigade JP | J Antimicrob Chemother | 10.1093/jac/dkab488 | 2022 | |
| Subinhibitory Concentrations of Antibiotics Exacerbate Staphylococcal Infection by Inducing Bacterial Virulence. | Gao P, Wei Y, Wan RE, Wong KW, Iu HTV, Tai SSC, Li Y, Yam HCB, Halebeedu Prakash P, Chen JHK, Ho PL, Yuen KY, Davies J, Kao RYT | Microbiol Spectr | 10.1128/spectrum.00640-22 | 2022 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive138348.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License